JP2022551551A - ロングリードシークエンシングを用いたゲノム構造バリアントの同定 - Google Patents

ロングリードシークエンシングを用いたゲノム構造バリアントの同定 Download PDF

Info

Publication number
JP2022551551A
JP2022551551A JP2022506030A JP2022506030A JP2022551551A JP 2022551551 A JP2022551551 A JP 2022551551A JP 2022506030 A JP2022506030 A JP 2022506030A JP 2022506030 A JP2022506030 A JP 2022506030A JP 2022551551 A JP2022551551 A JP 2022551551A
Authority
JP
Japan
Prior art keywords
genomic
interest
grnas
crrna
genomic region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506030A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551551A5 (https=
Inventor
オワサ テイタム,
ジ リー,
Original Assignee
ブラックホーク ジェノミクス エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ブラックホーク ジェノミクス エルエルシー filed Critical ブラックホーク ジェノミクス エルエルシー
Publication of JP2022551551A publication Critical patent/JP2022551551A/ja
Publication of JP2022551551A5 publication Critical patent/JP2022551551A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2022506030A 2019-10-11 2020-10-12 ロングリードシークエンシングを用いたゲノム構造バリアントの同定 Pending JP2022551551A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962913886P 2019-10-11 2019-10-11
US62/913,886 2019-10-11
US202062981146P 2020-02-25 2020-02-25
US62/981,146 2020-02-25
PCT/US2020/055293 WO2021072394A1 (en) 2019-10-11 2020-10-12 Identification of genomic structural variants using long-read sequencing

Publications (2)

Publication Number Publication Date
JP2022551551A true JP2022551551A (ja) 2022-12-12
JP2022551551A5 JP2022551551A5 (https=) 2023-10-19

Family

ID=75436767

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506030A Pending JP2022551551A (ja) 2019-10-11 2020-10-12 ロングリードシークエンシングを用いたゲノム構造バリアントの同定

Country Status (5)

Country Link
US (1) US20230028445A1 (https=)
EP (1) EP4041916A4 (https=)
JP (1) JP2022551551A (https=)
CN (1) CN114555824A (https=)
WO (1) WO2021072394A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114752668B (zh) * 2022-05-13 2025-08-01 深圳市优圣康生物科技有限公司 Crispr、cas9靶向捕获长片段dna的贫血筛查试剂盒及其方法
CN115232866A (zh) * 2022-08-08 2022-10-25 南方医科大学皮肤病医院(广东省皮肤病医院、广东省皮肤性病防治中心、中国麻风防治研究中心) 一种基于纳米孔测序靶向富集细菌16S rRNA基因的测序方法
WO2025049355A1 (en) * 2023-08-26 2025-03-06 Duke University Compositions comprising nanoparticles for targeted delivery and methods of using the same
WO2025235828A2 (en) * 2024-05-08 2025-11-13 The General Hospital Corporation Engineered prime editors for treating genetic deafness
CN119662814B (zh) * 2025-02-20 2025-06-27 北京贝瑞和康生物技术有限公司 检测戈谢病gba1基因及其假基因gbap1多种突变的引物组、试剂盒及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017532042A (ja) * 2014-10-29 2017-11-02 10エックス ゲノミクス,インコーポレイテッド 標的化核酸配列決定のための方法及び組成物
JP2018509896A (ja) * 2015-02-27 2018-04-12 フリューダイム・コーポレイション 高処理能力研究用の単一細胞核酸

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3633047B1 (en) * 2014-08-19 2022-12-28 Pacific Biosciences of California, Inc. Method of sequencing nucleic acids based on an enrichment of nucleic acids
KR102888521B1 (ko) * 2015-04-06 2025-11-19 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017532042A (ja) * 2014-10-29 2017-11-02 10エックス ゲノミクス,インコーポレイテッド 標的化核酸配列決定のための方法及び組成物
JP2018509896A (ja) * 2015-02-27 2018-04-12 フリューダイム・コーポレイション 高処理能力研究用の単一細胞核酸

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Amplification-free, CRISPR-Cas9 Targeted Enrichment and SMRT Sequencing of Repeat-Expansion Disease", BIORXIV, JPN6024050390, 16 October 2017 (2017-10-16), ISSN: 0005606978 *
"Targeted Nanopore Sequencing with Cas9 for studies of methylation, structual variants, and mutations", BIORXIV, JPN6024050389, 4 June 2019 (2019-06-04), ISSN: 0005606980 *
LABORATORY INVESTIGATION, vol. 100, JPN6024050392, 2020, pages 135 - 146, ISSN: 0005606979 *
PLOS ONE, vol. 14, no. 4, JPN6024050391, 18 April 2019 (2019-04-18), pages 0215441, ISSN: 0005482512 *

Also Published As

Publication number Publication date
EP4041916A1 (en) 2022-08-17
CN114555824A (zh) 2022-05-27
US20230028445A1 (en) 2023-01-26
WO2021072394A1 (en) 2021-04-15
EP4041916A4 (en) 2023-11-01

Similar Documents

Publication Publication Date Title
JP2022551551A (ja) ロングリードシークエンシングを用いたゲノム構造バリアントの同定
Ergin et al. RNA sequencing and its applications in cancer and rare diseases
Macaulay et al. G&T-seq: parallel sequencing of single-cell genomes and transcriptomes
McGaughey et al. Genomics of CpG methylation in developing and developed zebrafish
Tsai et al. Amplification-free, CRISPR-Cas9 targeted enrichment and SMRT sequencing of repeat-expansion disease causative genomic regions
Denker et al. The second decade of 3C technologies: detailed insights into nuclear organization
Shin et al. Decoding neural transcriptomes and epigenomes via high-throughput sequencing
EP3699292B1 (en) High-throughput genotyping by sequencing low amounts of genetic material
Elurbe et al. Regulatory remodeling in the allo-tetraploid frog Xenopus laevis
Langevin et al. Peregrine: a rapid and unbiased method to produce strand-specific RNA-Seq libraries from small quantities of starting material
JP2022505050A (ja) プーリングを介した多数の試料の効率的な遺伝子型決定のための方法および試薬
You et al. Detection of genome-wide low-frequency mutations with Paired-End and Complementary Consensus Sequencing (PECC-Seq) revealed end-repair-derived artifacts as residual errors
Magar et al. Gene expression and transcriptome sequencing: basics, analysis, advances
Løvendorf et al. Knockdown of circular RNAs using LNA-modified antisense oligonucleotides
US20160098516A1 (en) Methods and systems for detection of a genetic mutation
JP2024056984A (ja) エピジェネティック区画アッセイを較正するための方法、組成物およびシステム
Blighe et al. Gene editing in the context of an increasingly complex genome
Jaksik et al. RNA-seq library preparation for comprehensive transcriptome analysis in cancer cells: the impact of insert size
JP2022514010A (ja) 核酸分子の回収率を改善するための方法、組成物、およびシステム
US20240233871A9 (en) Methods for the non-invasive detection and monitoring of therapeutic nucleic acid constructs
CN114746560A (zh) 改进甲基化多核苷酸结合的方法、组合物和系统
Oh et al. From genome sequencing to the discovery of potential biomarkers in liver disease
Do et al. Transcriptome analysis of non‐coding RNAs in livestock species: elucidating the ambiguity
Katsantoni Omics Studies in Hemoglobinopathies: E. Katsantoni
Cromwell et al. Methods for measuring CRISPR/Cas9 DNA cleavage in cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231011

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231011

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241211

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250530